Since the original papers were published, the management of type 1 diabetes has advanced: continuous and flash glucose monitoring give us a much better idea of glucose variability within an individual, and we now regularly measure C-peptide levels and are starting to get a clearer view of residual beta-cell function in people with type 1 diabetes
10.1007/s00429-014-0714-z Summary Keywords GLP-1, obesity, diabetes, CNS, insulin Citation Heppner KM and Perez-Tilve D (2015) GLP-1 based therapeutics: simultaneously combating T2DM and obesity
However, the medication can typically be kept at room temperature (below 86F / 30C) for up to 21 days if necessary
The peptide is eliminated primarily through renal excretion without requiring hepatic metabolism
Whether you're recovering from an injury, dealing with gut issues, or just want to feel better overall, this peptide therapy can help you get back to feeling your best.
The components are available individually too